Bone-Immune Cell Crosstalk: Bone Diseases

Bone diseases are associated with great morbidity; thus, the understanding of the mechanisms leading to their development represents a great challenge to improve bone health. Recent reports suggest that a large number of molecules produced by immune cells affect bone cell activity. However, the mechanisms are incompletely understood. This review aims to shed new lights into the mechanisms of bone diseases involving immune cells. In particular, we focused our attention on the major pathogenic mechanism underlying periodontal disease, psoriatic arthritis, postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, metastatic solid tumors, and multiple myeloma.

• Publication year

  2015

• Venue

  Journal of Immunological Research

• Publication date

  2015-04-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2015/108451PMID 26000310PMCID 4427089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Impact of Immune System in Regulating Bone Metastasis Formation by Osteotropic Tumors

  2015cited by this paper
• Human Myeloma Cell Lines Induce Osteoblast Downregulation of CD99 Which Is Involved in Osteoblast Formation and Activity

  2015cited by this paper
• Interleukin‐17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1‐JNK/NF‐κB pathways

  2015cited by this paper
• Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review

  2014cited by this paper
• Ustekinumab for the treatment of psoriatic arthritis: an update

  2014cited by this paper
• A Phase IB multicentre dose‐determination study of BHQ880 in combination with anti‐myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal‐related events

  2014cited by this paper
• Glucocorticoid-induced osteoporosis: 2013 update.

  2014cited by this paper
• Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression

  2014cited by this paper
• LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease

  2014cited by this paper
• The New Insight into the Role of Antimicrobial Proteins-Alarmins in the Immunopathogenesis of Psoriasis

  2014cited by this paper
• Treatment of osteoporosis in children with glucocorticoid-treated diseases

  2014cited by this paper
• Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis.

  2014cited by this paper
• Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow

  2013cited by this paper
• Inflammation and breast cancer

  2013cited by this paper
• T Cells Induce Pre-Metastatic Osteolytic Disease and Help Bone Metastases Establishment in a Mouse Model of Metastatic Breast Cancer

  2013cited by this paper
• Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

  2013cited by this paper
• Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis

  2013cited by this paper
• Porphyromonas gingivalis Infection-Associated Periodontal Bone Resorption Is Dependent on Receptor Activator of NF-κB Ligand

  2013cited by this paper
• Myeloid-Derived Suppressor Cells in the Development of Lung Cancer

  2013cited by this paper
• The Interplay between the Bone and the Immune System

  2013cited by this paper
• Immune regulation of bone loss by Th17 cells in oestrogen‐deficient osteoporosis

  2013cited by this paper
• Bone metastases in gastric cancer follow a RANKL-independent mechanism.

  2013cited by this paper
• High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment.

  2013cited by this paper
• Down-regulation of PLCγ2–β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer

  2013cited by this paper
• Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease.

  2013cited by this paper
• Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis.

  2013cited by this paper
• Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.

  2013cited by this paper
• Osteoblast and osteoclast crosstalks: from OAF to Ephrin.

  2012cited by this paper
• Increased numbers of T helper 17 cells and the correlation with clinicopathological characteristics in multiple myeloma.

  2012cited by this paper
• Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art.

  2012cited by this paper
• Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

  2012cited by this paper
• Increased Numbers of T Helper 17 Cells and the Correlation with Clinicopathological Characteristics in Multiple Myeloma

  2012cited by this paper
• T cell‐mediated increased osteoclast formation from peripheral blood as a mechanism for crohn's disease‐associated bone loss

  2012cited by this paper
• Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of Osteoporosis

  2012cited by this paper
• Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.

  2012cited by this paper
• Adipokines in Psoriatic Arthritis Patients: The Correlations with Osteoclast Precursors and Bone Erosions

  2012cited by this paper
• Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells

  2012cited by this paper
• Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss*

  2012cited by this paper
• Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

  2012cited by this paper
• Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures

  2011cited by this paper
• Myeloma cells suppress osteoblasts through sclerostin secretion

  2011cited by this paper
• Clinical practice. Glucocorticoid-induced bone disease.

  2011cited by this paper
• Maternal smoking during pregnancy and offspring growth in childhood: 1993 and 2004 Pelotas cohort studies

  2011cited by this paper
• Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis

  2011cited by this paper
• Cancer to bone: a fatal attraction

  2011cited by this paper
• Microbial shift and periodontitis.

  2011cited by this paper
• Membrane-bound CD40 ligand on T cells from mice injected with lipopolysaccharide accelerates lipopolysaccharide-induced osteoclastogenesis.

  2011cited by this paper
• Alendronate reduces osteoclast precursors in osteoporosis

  2010cited by this paper
• Inhibition of antigen presentation and T cell costimulation blocks PTH‐induced bone loss

  2010cited by this paper
• Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.

  2010cited by this paper
• Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

  2010cited by this paper
• The immune system and bone.

  2010cited by this paper
• MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR.

  2010cited by this paper
• Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues.

  2010cited by this paper
• The Role of Circulating Bone Cell Precursors in Fracture Healing

  2010cited by this paper
• Cellular and Molecular Mechanisms of Bone Remodeling*

  2010cited by this paper
• A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.

  2010cited by this paper
• Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.

  2010cited by this paper
• Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors

  2010cited by this paper
• Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand

  2010cited by this paper
• Psoriatic arthritis: from pathogenesis to therapy

  2009cited by this paper
• Pathogenesis of myeloma bone disease

  2009influential reference
• Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.

  2009cited by this paper
• Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.

  2009cited by this paper
• Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients

  2009cited by this paper
• Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

  2009cited by this paper
• Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective

  2009cited by this paper
• Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria.

  2009cited by this paper
• Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients

  2008cited by this paper
• Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells

  2008cited by this paper
• Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.

  2008cited by this paper
• Molecular mechanisms and treatment of bone metastasis

  2008cited by this paper
• Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis.

  2008cited by this paper
• Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.

  2008cited by this paper
• T cells potentiate PTH-induced cortical bone loss through CD40L signaling.

  2008cited by this paper
• Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

  2008influential reference
• Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis

  2008cited by this paper
• The Impact of Hormone Replacement Therapy on Humoral and Cell‐mediated Immune Responses In Vivo in Post‐menopausal Women with Rheumatoid Arthritis

  2008cited by this paper
• METASTASIS TO BONE : CAUSES , CONSEQUENCES AND THERAPEUTIC OPPORTUNITIES

  2007cited by this paper
• IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation

  2007cited by this paper
• Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

  2007cited by this paper
• B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.

  2007influential reference
• Molecular analysis of RANKL‐independent cell fusion of osteoclast‐like cells induced by TNF‐α, lipopolysaccharide, or peptidoglycan

  2007cited by this paper
• A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

  2007cited by this paper
• Effect of Blockade of TNF‐α and Interleukin‐1 Action on Bone Resorption in Early Postmenopausal Women

  2007cited by this paper
• IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.

  2007cited by this paper
• Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL‐7 in an in vitro model derived from human psoriatic arthritis

  2007cited by this paper
• IL‐7 Modulates Osteoclastogenesis in Patients Affected by Solid Tumors

  2007cited by this paper
• Lymphocytes and the Dap12 Adaptor Are Key Regulators of Osteoclast Activation Associated with Gonadal Failure

  2007cited by this paper
• The Role of OPG/TRAIL Complex in Multiple Myeloma

  2006cited by this paper
• Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer

  2006cited by this paper
• Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

  2006influential reference
• Glucocorticoid-induced osteoporosis: an update.

  2006cited by this paper
• Osteoclasts, rheumatoid arthritis, and osteoimmunology

  2006cited by this paper
• B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

  2006cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.

  2006cited by this paper
• Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down‐regulation of receptor activator of nuclear factor‐kappaB and c‐Fos

  2006cited by this paper
• Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients.

  2006cited by this paper
• Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.

  2006cited by this paper

• Bone health and body composition in Indian girls with Turner syndrome: analysis based on therapeutic interventions

  2025cites this paper
• TLR-4Ab and IFNγAb with exogenous IL-10 treated LPS induced mice shown differential inflammatory response upon RANKL-M-CSF stimulation in Resident Bone Marrow Cells.

  2025cites this paper
• Cancer treatment-induced bone loss

  2024cites this paper
• Estrogen deficiency‐mediated osteoimmunity in postmenopausal osteoporosis

  2024cites this paper
• Estrogen Deficiency alters Vascularization and Mineralization dynamics: insight from a novel 3D Humanized and Vascularized Bone Organoid Model

  2024cites this paper
• Osteoinduction and osteoimmunology: Emerging concepts.

  2023cites this paper
• Bone Cell Exosomes and Emerging Strategies in Bone Engineering

  2022cites this paper
• Analysis of the effects of turmeric and symbiotic consumption on bones of rats submitted to the use of dexamethasone.

  2022cites this paper
• Energy metabolism in bone tumors

  2022cites this paper
• A practical guide for evaluating the osteoimmunomodulatory properties of biomaterials.

  2021cites this paper
• The Effect of Inflammation on Bone

  2021cites this paper
• ERR  expression in bone metastases leads to an exacerbated anti-tumor immune

  2021cites this paper
• Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets

  2021cites this paper
• A novel coating with universal adhesion and inflammation-responsive drug release functions to manipulate the osteoimmunomodulation of implants.

  2021cites this paper
• Naturally occurring coumestans from plants, their biological activities and therapeutic effects on human diseases.

  2021cites this paper
• Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma

  2020cites this paper
• Could Vitamin D Influence Risk for Periodontal Disease—to “D” or Not to “D”?

  2020cites this paper
• ERRa Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response

  2020cites this paper
• A Comprehensive Analysis of MicroRNAs in Human Osteoporosis

  2020cites this paper
• Isoflavone-enriched soybean leaves attenuate ovariectomy-induced osteoporosis in rats by anti-inflammatory activity.

  2020cites this paper
• Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL‐induced osteoclastogenesis

  2020cites this paper
• Osteoimmunology: The Regulatory Roles of T Lymphocytes in Osteoporosis

  2020cites this paper
• ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response

  2020cites this paper
• Network and pathway-based analyses of genes associated with osteoporosis

  2020cites this paper
• Editorial: Updates on Osteoimmunology: What's New on the Crosstalk Between Bone and Immune Cells

  2020cites this paper
• Connections Between Gut Microbiota and Bone Health

  2019cites this paper
• Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma

  2019cites this paper
• Tumors of Bone

  2019cites this paper
• Non-neurologic Late Effects of Therapy

  2019cites this paper
• Androgens, Androgen Receptor, and Bone

  2019cites this paper
• Osteoporosis, Inflammation, and Aging

  2019cites this paper
• Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption

  2018cites this paper
• Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells

  2018cites this paper
• Improved RANKL production by memory B cells: A way for B cells promote alveolar bone destruction during periodontitis

  2018cites this paper
• A Lox/CHOP‐10 crosstalk governs osteogenic and adipogenic cell fate by MSCs

  2018cites this paper
• Magnesium Lithospermate B Protects against Lipopolysaccharide-Induced Bone Loss by Inhibiting RANKL/RANK Pathway

  2018cites this paper
• Skeletal Tissue and Ovarian Function: Puberty and Menopause

  2018cites this paper
• Mechanisms of Osteolytic and Osteoblastic Skeletal Lesions

  2018cites this paper
• Link between estrogen deficiency osteoporosis and susceptibility to bone metastases: A way towards precision medicine in cancer patients.

  2018cites this paper
• SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation

  2018cites this paper
• Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis

  2018cites this paper
• Resveratrol restores the level of key inflammatory cytokines and RANKL/OPG ratio in the femur of rat osteoporosis model

  2018cites this paper
• Loss of stat3 function leads to spine malformation and immune disorder in zebrafish.

  2017cites this paper
• Editorial: Bone: Endocrine Target and Organ

  2017cites this paper
• Psoriatic arthritis and periodontal disease. Is there a link between them and whether microbiome-oriented treatment could influence the course of arthritis in the future?

  2017cites this paper
• RECOGNISING BONE REMODELING PHENOTYPES IN ADDITION TO CLINICAL AND INFLAMMATORY PHENOTYPES IN CFBD

  2017cites this paper
• An Evidence-Based Approach to Myeloma Bone Disease

  2017influential citation
• Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity

  2017cites this paper
• Hallmarks of Bone Metastasis

  2017cites this paper
• The Cell Surface Markers Expression in Postmenopausal Women and Relation to Obesity and Bone Status

  2017cites this paper
• Risk of vertebral compression fractures in multiple myeloma patients

  2017cites this paper
• Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey

  2017cites this paper
• Gut Microbiota, Immune System, and Bone

  2017cites this paper
• Mechanisms of Altered Bone Remodeling in Multiple Myeloma

  2017cites this paper
• Impact of the adaptive immune system in bone fracture healing

  2017cites this paper
• A possible new mechanism and drug intervention for kidney damage due to arsenic poisoning in rats.

  2016cites this paper
• INTERACTIONS BETWEEN SKELETAL SYSTEM AND MACROPHAGES IN HOMEOSTASIS AND BONE INJURY

  2016cites this paper
• The pathogenesis of chronic chikungunya: evolving concepts

  2016cites this paper
• The best of both worlds — managing the cancer, saving the bone

  2016cites this paper
• The Effect of Long-Term Exercise on the Production of Osteoclastogenic and Antiosteoclastogenic Cytokines by Peripheral Blood Mononuclear Cells and on Serum Markers of Bone Metabolism

  2016cites this paper
• Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies

  2016cites this paper
• Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis

  2016cites this paper
• Exercise, interleukins and bone homeostasis

  2016cites this paper
• Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.

  2015cites this paper